Cabaletta Bio Inc

NASDAQ:CABA  
5.96
+0.43 (+7.78%)
7:16:33 PM EDT: $5.93 -0.03 (-0.50%)
Earnings Announcements

Cabaletta Bio Reports Q3 2022 Financial Results

Published: 11/10/2022 12:53 GMT
Cabaletta Bio Inc (CABA) - Cabaletta Bio Reports Third Quarter 2022 Financial Results and Provides Business Update.
Cabaletta Bio - As of September 30, 2022, Co Had Cash, Cash Equivalents and Investments of $85.9 Million, Compared to $122.2 Million As of December 31, 2021.
Cabaletta Bio - Expects That Cash, Cash Equivalents,investments As of September 30, 2022, Will Enable It to Fund Its Operating Plan Through Q2 of 2024.
Qtrly Loss per Share $0.39.
Q3 Earnings per Share View $-0.48 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.48

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.43

More details on our Analysts Page.